sta-21 (ochromycinone) (Cayman Chemical)
90
Structured Review
Cayman Chemical
sta-21 (ochromycinone)
Sta 21 (Ochromycinone), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sta+21/sta+21++ochromycinone+/pm37802209-71-25-27
Average 90 stars, based on 1 article reviews
Sta 21 (Ochromycinone), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sta+21/sta+21++ochromycinone+/pm37802209-71-25-27
Average 90 stars, based on 1 article reviews
sta-21 (ochromycinone) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Activation Assay:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Expressing:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. In Vitro:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Binding Assay:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Cell Culture:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Western Blot:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. Sequencing:Article Title: Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A 2 . Article Snippet: As required for the experiments, dorsal and ventral surfaces of the ears were daily topically treated with LyPls-PLD in 50 mM Article Title: Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways Article Snippet: In another set of experiments, Th17 or act-A–Th17 cells (3 × 10 6 ), generated as above, were treated with anti-CD73 blocking antibody (BioXCell; 20 μg/mL) or IgG control, and then adoptively transferred to C57BL/6- Rag1 −/− mice (day 0) as above. |